Ignite Creation Date:
2024-05-06 @ 7:41 PM
Last Modification Date:
2024-10-26 @ 3:11 PM
Study NCT ID:
NCT06099808
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-04-17
First Post:
2023-10-18
Brief Title:
Veterans Affairs Pharmacist Heart Failure Medication Titration Project 1
Sponsor:
Stanford University
Organization:
Stanford University
Study Overview
Official Title:
Randomized Evaluation of Audit and Feedback Intervention to Promote Pharmacist Heart Failure Medication Titration in Veterans Affairs Sierra Pacific Network
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a randomized quality improvement project to evaluate the impact of an audit and feedback intervention to motivate pharmacists to provide heart failure HF medication management to patients in the Veterans Health Administration VHA Sierra Pacific region VISN 21 The results of this project could provide guidance for how to successfully scale a pharmacist-based HF remote management program in the VHA more broadly
Pharmacists providing clinical care as part of Patient Aligned Care Team PACT within VHA VISN 21 will be included Pharmacists will be randomized to one of 3 arms in a 112 ratio 1 monthly audit and feedback of HF medication titration activities AF vs 2 educational resources and monthly notification of HF medication titration actions in addition to a list of potential patients for HF optimization AF vs 3 usual care without audit and feedback UC Pharmacists across all three arms will be given access to shared educational resources on HF pharmacist care and educational webinars Six months after the intervention rates of pharmacist HF medication titration encounters will be compared among the 3 groups
Pharmacists providing clinical care as part of Patient Aligned Care Team PACT within VHA VISN 21 will be included Pharmacists will be randomized to one of 3 arms in a 112 ratio 1 monthly audit and feedback of HF medication titration activities AF vs 2 educational resources and monthly notification of HF medication titration actions in addition to a list of potential patients for HF optimization AF vs 3 usual care without audit and feedback UC Pharmacists across all three arms will be given access to shared educational resources on HF pharmacist care and educational webinars Six months after the intervention rates of pharmacist HF medication titration encounters will be compared among the 3 groups
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None